- Home
- QNRX vs BENF Comparison
QNRX vs BENF Comparison
Compare QNRX & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- BENF
- Stock Information
- Founded
- QNRX 2018
- BENF 2003
- Country
- QNRX United States
- BENF United States
- Employees
- QNRX N/A
- BENF N/A
- Industry
- QNRX Medical/Dental Instruments
- BENF Blank Checks
- Sector
- QNRX Health Care
- BENF Finance
- Exchange
- QNRX Nasdaq
- BENF Nasdaq
- Market Cap
- QNRX 4.8M
- BENF 5.3M
- IPO Year
- QNRX N/A
- BENF N/A
- Fundamental
- Price
- QNRX $13.03
- BENF $0.85
- Analyst Decision
- QNRX
- BENF
- Analyst Count
- QNRX 0
- BENF 0
- Target Price
- QNRX N/A
- BENF N/A
- AVG Volume (30 Days)
- QNRX 833.5K
- BENF 53.2M
- Earning Date
- QNRX 11-07-2025
- BENF 10-21-2025
- Dividend Yield
- QNRX N/A
- BENF N/A
- EPS Growth
- QNRX N/A
- BENF N/A
- EPS
- QNRX N/A
- BENF N/A
- Revenue
- QNRX N/A
- BENF N/A
- Revenue This Year
- QNRX N/A
- BENF N/A
- Revenue Next Year
- QNRX N/A
- BENF $28.83
- P/E Ratio
- QNRX N/A
- BENF N/A
- Revenue Growth
- QNRX N/A
- BENF N/A
- 52 Week Low
- QNRX $5.01
- BENF $0.22
- 52 Week High
- QNRX $48.30
- BENF $2.36
- Technical
- Relative Strength Index (RSI)
- QNRX 54.33
- BENF 55.56
- Support Level
- QNRX $12.00
- BENF $0.45
- Resistance Level
- QNRX $17.84
- BENF $1.50
- Average True Range (ATR)
- QNRX 4.54
- BENF 0.15
- MACD
- QNRX -0.02
- BENF 0.04
- Stochastic Oscillator
- QNRX 16.87
- BENF 38.09
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and a financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.